Loading…

Ginsenoside Rg1 activates brown adipose tissue to counteract obesity in high-fat diet-fed mice by regulating gut microbes and bile acid composition

Obesity is a global health problem strongly linked to gut microbes and their metabolites. In this study, ginsenoside Rg1 (Rg1) reduced lipid droplet size and hepatic lipid accumulation by activating uncoupling protein 1 expression in brown adipose tissue (BAT), which in turn inhibited high-fat diet...

Full description

Saved in:
Bibliographic Details
Published in:Food & function 2023-05, Vol.14 (1), p.4696-475
Main Authors: Liu, Yize, Jin, Zheng-Yun, Wang, Jun-Xia, Wang, Danqi, Liu, Hongye, Li, Dongxu, Zhu, Jun, Luo, Zhao-Bo, Han, Sheng-Zhong, Chang, Shuang-Yan, Yang, Liu-Hui, Kang, Jin-Dan, Quan, Lin-Hu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obesity is a global health problem strongly linked to gut microbes and their metabolites. In this study, ginsenoside Rg1 (Rg1) reduced lipid droplet size and hepatic lipid accumulation by activating uncoupling protein 1 expression in brown adipose tissue (BAT), which in turn inhibited high-fat diet (HFD)-induced weight gain in mice. Furthermore, the intestinal flora of mice was altered, the abundance of Lachnoclostridium , Streptococcus , Lactococcus , Enterococcus and Erysipelatoclostridium was upregulated, and the concentrations of fecal bile acids were altered, with cholic acid and taurocholic acid concentrations being significantly increased. In addition, the beneficial effects of Rg1 were eliminated in mice treated with a combination of antibiotics. In conclusion, these results suggest that Rg1 activates BAT to counteract obesity by regulating gut microbes and bile acid composition in HFD-fed mice. Ginsenoside Rg1 activates brown adipose tissue by modulating intestinal microbial and bile acid components to fight obesity in HFD-induced mice.
ISSN:2042-6496
2042-650X
DOI:10.1039/d2fo03142f